Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HUM vs GSK✓SelectedUSD · GSKHUM vs GSK performance historyLatest closeAs of-1.50%11/19
Stock and ETF performance explorer

HUM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+5,285.2%
GSK return
+1,646.5%
Excess return
+3,638.7%
Maximum drawdown
-85.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.5%-1.6%+0.1%-1.0%
7D-14.4%-4.7%-9.6%-12.9%
30D-10.9%-4.7%-6.2%-9.5%
3M+0.7%-8.8%+9.5%+3.6%
6M+22.9%-4.6%+27.5%+23.9%
YTD+49.8%+1.0%+48.8%+46.9%
1Y+68.2%+6.9%+61.3%+61.8%
3Y-20.9%+52.5%-73.4%-34.5%
5Y-8.1%+40.3%-48.4%-22.7%
10Y+106.7%+99.0%+7.8%+53.0%
All+5,285.2%+1,646.5%+3,638.7%+1,572.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling